NO940400L - Farmasöytisk preparat inneholdene karbakol og andre kolinergiske stoffer - Google Patents

Farmasöytisk preparat inneholdene karbakol og andre kolinergiske stoffer

Info

Publication number
NO940400L
NO940400L NO940400A NO940400A NO940400L NO 940400 L NO940400 L NO 940400L NO 940400 A NO940400 A NO 940400A NO 940400 A NO940400 A NO 940400A NO 940400 L NO940400 L NO 940400L
Authority
NO
Norway
Prior art keywords
carbacol
pharmaceutical preparation
preparation containing
cholinergic
cholinergic substances
Prior art date
Application number
NO940400A
Other languages
English (en)
Other versions
NO306447B1 (no
NO940400D0 (no
Inventor
Rudolph Wolfgang Hahnenberger
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO940400L publication Critical patent/NO940400L/no
Publication of NO940400D0 publication Critical patent/NO940400D0/no
Publication of NO306447B1 publication Critical patent/NO306447B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
NO940400A 1991-08-13 1994-02-07 Anvendelse av kolinerg substans for behandling av törre öyne NO306447B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9102340A SE9102340D0 (sv) 1991-08-13 1991-08-13 Pharmaceutical composition containing carbachol and othercholinergic substances
PCT/SE1992/000542 WO1993003718A1 (en) 1991-08-13 1992-08-07 Pharmaceutical composition containing carbachol and other cholinergic substances

Publications (3)

Publication Number Publication Date
NO940400L true NO940400L (no) 1994-02-07
NO940400D0 NO940400D0 (no) 1994-02-07
NO306447B1 NO306447B1 (no) 1999-11-08

Family

ID=20383456

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940400A NO306447B1 (no) 1991-08-13 1994-02-07 Anvendelse av kolinerg substans for behandling av törre öyne

Country Status (14)

Country Link
US (1) US5679713A (no)
EP (2) EP0661968B1 (no)
JP (1) JPH06509801A (no)
AT (1) ATE172114T1 (no)
AU (1) AU671805B2 (no)
CA (1) CA2114239C (no)
DE (1) DE69227324T2 (no)
DK (1) DK0661968T3 (no)
ES (1) ES2123005T3 (no)
FI (1) FI108516B (no)
HU (1) HU221592B (no)
NO (1) NO306447B1 (no)
SE (1) SE9102340D0 (no)
WO (1) WO1993003718A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998036733A2 (en) * 1997-02-24 1998-08-27 Michael Albert Kamm Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
US6711436B1 (en) 1997-08-08 2004-03-23 Duke University Compositions, apparatus and methods for facilitating surgical procedures
DE69833665T2 (de) 1997-08-08 2006-11-09 Duke University Zusammensetzungen zur vereinfachung von chirurgischen verfahren
US6395758B1 (en) * 1998-08-14 2002-05-28 Gpi Nil Holdings, Inc. Small molecule carbamates or ureas for vision and memory disorders
US7220422B2 (en) * 2003-05-20 2007-05-22 Allergan, Inc. Methods and compositions for treating eye disorders
US8299079B2 (en) 2009-05-22 2012-10-30 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
MX2012005456A (es) 2009-11-12 2012-06-19 Acacia Pharma Ltd Uso de betanecol para el tratamiento de xerostomia.
JP2016196454A (ja) * 2015-04-03 2016-11-24 参天製薬株式会社 涙腺ドラッグデリバリーシステム

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2185220A (en) * 1938-08-17 1940-01-02 Smith Kline French Lab Medicinal agent
GB1386864A (en) * 1972-02-11 1975-03-12 Avicon Inc Micro-crystalline collage-containing pharmaceutical compositions useful for topical applications
US4804539A (en) * 1986-07-28 1989-02-14 Liposome Technology, Inc. Ophthalmic liposomes
JPH02500360A (ja) * 1986-07-28 1990-02-08 リポソーム　テクノロジー，インコーポレイテッド 粘膜組織上での高い保持力を有するリポソーム

Also Published As

Publication number Publication date
CA2114239A1 (en) 1993-02-14
FI940637A0 (fi) 1994-02-11
US5679713A (en) 1997-10-21
JPH06509801A (ja) 1994-11-02
EP0661968B1 (en) 1998-10-14
CA2114239C (en) 2003-10-21
ATE172114T1 (de) 1998-10-15
NO306447B1 (no) 1999-11-08
FI940637L (fi) 1994-02-11
ES2123005T3 (es) 1999-01-01
HU221592B (hu) 2002-11-28
AU671805B2 (en) 1996-09-12
HU9400405D0 (en) 1994-05-30
WO1993003718A1 (en) 1993-03-04
DE69227324T2 (de) 1999-04-29
AU2463192A (en) 1993-03-16
DE69227324D1 (de) 1998-11-19
HUT65946A (en) 1994-08-29
EP0528776A1 (en) 1993-02-24
SE9102340D0 (sv) 1991-08-13
DK0661968T3 (da) 1999-06-23
EP0661968A1 (en) 1995-07-12
FI108516B (fi) 2002-02-15
NO940400D0 (no) 1994-02-07

Similar Documents

Publication Publication Date Title
TW264480B (no)
IL126038A0 (en) Novel benzothiepines and derivatives thereof and pharmaceutical compositions comprising them
BG101118A (en) Therapeutical compounds
ATE207342T1 (de) Gegen hautalterung wirksame stoffe oder wirkstoffkombinationen und zubereitungen
ATE140388T1 (de) Zusammensetzungen enthaltend omega conotoxin peptide derivate und deren verwendung zur behandlung von ischämie-artigen neuronalen schädigungen
NO982310L (no) Protegriner
KR930012022A (ko) 뇌조직 보호용 모다피닐(Modafinil)
AU2905092A (en) Pharmaceutical dipeptide compositions and methods of use thereof
NO940266L (no) Indre strålingsskade
KR960700721A (ko) Aids-관련 신경 장애를 치료하기 위한 라모트리진의 사용(use of lamotrigine for treating aids-related neural disorders)
DE69531098D1 (de) Piperidine und pyrrolidine
DE69826023D1 (de) Verwendung von substanzen mit oxytocinwirkung zur herstellung eines arzneimittels zur behandlung affektiver schmerzsyndrome
RU95111308A (ru) Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция
BR9500436A (pt) Produtos uso de um g-csf uso de uma proteína tnf ligante processo para o tratamento e/ou prevenção do choque séptico
NO940400L (no) Farmasöytisk preparat inneholdene karbakol og andre kolinergiske stoffer
DE69927584D1 (de) Pharmazeutische zubereitungen zur behandlung von magengeschwüren
NO990440L (no) Preparat som innbefatter mupirocin og klorheksidin
WO2000072833A3 (de) Pharmazeutische zubereitungen zur hemmung von spimgomyelinase
NO934832D0 (no) Farmasoeytisk sammensetning for forhindring eller behandling av ar terioscherose
BR9813098A (pt) Uso de glicosaminoglicans, preparação farmacêutica, e, combinaçào
NO922635D0 (no) Ny anvendelse av benzimidazolin-2-okso-1-karboksylsyrederivater
RU92004541A (ru) Лекарственные средства для лечения воспалительных состояний или для аналгезии
BG95724A (en) Medicaments with analgetic, antiphlogestic and antibacterial effect for external use
RU93053043A (ru) Новые производные тиомаринола, способ их получения, фармацевтическая композиция и способ лечения
AU628492B2 (en) Improvements in chemical compounds